Cystic fibrosis (CF), the most common lethal genetic disease in Caucasians, is associated with defective regulation of Clsecretion by epithelial cells (1) . In CF cells, cAMP fails to induce Cl-secretion (1) (2) (3) . CF is caused by mutations in the gene for the CF transmembrane conductance regulator (CFTR; refs. 4 and 5) . Expression of wild-type CFTR in CF cells restores cAMP-dependent Cl-current regulation (6, 7) . Moreover, epithelial and nonepithelial cells lacking endogenous CFTR acquire cAMP-regulated Cl-current after transfection with the CFTR gene (2, 3) . The selectivity and regulation of this current are altered by site-directed mutagenesis of the CFTR, demonstrating that phosphorylation of CFTR by cAMP-dependent protein kinase (PKA) followed by binding of ATP activates Cl-movement (8) (9) (10) . CFTR (11) or even its first nucleotide binding fold (12) act as Cl--specific pores in lipid bilayers, establishing that CFTR is in fact a Cl-channel.
Cl-secretion in epithelial cells is also stimulated by the Ca2+-triggered pathways, some of which are preserved in CF epithelial cells (13) (14) (15) (16) . Activation by Ca2+ is mediated by calmodulin and calcium/calmodulin-dependent protein kinase (CaMK) in T84 colonic epithelial cells and transformed normal and CF airway epithelial cells (16, 17) . A variety of experimental findings, such as the preservation of Ca2+-but not cAMP-dependent Cl-flux in CF airway cells (13) (14) (15) (16) ,
imply that the Ca2+ pathway is independent of CFTR. This inference can be most directly tested by eliminating CFTR. We used antisense oligodeoxynucleotide treatment to lower the amount of CFTR in colonic (T84) and tracheal airway epithelial cells (56FHTE-8o-; ref. 16) . Antisense treatment should then reduce the cAMP-activated Cl-current without affecting the Ca2+-activated Cl-current. We monitored CFTR protein by immunoprecipitation followed by in vitro phosphorylation. Whole-cell patch clamp served to distinguish between cAMP-activated and Ca2+-activated Cl-currents.
MATERIALS AND METHODS Oligonucleotides. Antisense oligodeoxynucleotide treatment has been used to block the expression of oncogenes and kinases (18) . Antisense oligomers are typically directed to the initial nucleotides of the target mRNA. Cells are incubated with pairs of oligomers that are 15-22 nucleotides long (18) . Longer oligomers do not readily enter cells, and shorter ones do not anneal to target mRNAs with sufficient specificity. The antisense oligodeoxynucleotides used in this study are a pair of adjoining 18-mers (5'-CAGAGGCGACCTCTG-CAT-3' and 5'-GACAACGCTGGCCTTTTC-3') that are complementary to nucleotides 1-18 and 19-36 of CFTR mRNA (nucleotide 1 begins with the AUG codon) (5) . Two pairs of oligomers were used as controls. The pair of sense oligodeoxynucleotides (5'-ATGCAGAGGTCGCCTCTG-3' and 5'-GAAAAGGCCAGCGTTGTC-3') have a sequence corresponding to that of the mRNA (5) . In addition, a pair of misantisense oligodeoxynucleotides (5'-CAGCGGCGAC-CGATGCAG-3' and 5'-GACAACTCTGGACGTTTA-3') were synthesized having the same sequence as the antisense pair except for the presence of four mismatches in each. Oligodeoxynucleotides were synthesized on an Applied Biosystems DNA synthesizer and then purified by HPLC (16) . The membrane was voltage-clamped to a holding potential of -70 mV and stepped to levels between -100 and +100 mV in 50-mV increments. Voltage steps were 500 ms in duration with 750-ms intervals between steps. Variation in the plasma membrane area of different cells was taken into account by normalizing the current to cell membrane capacitance (pA/ pF). Cells were monitored by whole-cell voltage clamp for at least 12 min after addition of 400 1AM 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate (CPTcAMP), a membrane-soluble cAMP analog, or of 1 .uM ionomycin, a calcium ionophore. A positive response was defined as a >2-fold increase in normalized current measured at +100 mV compared to baseline levels. RESULTS Effect of Oligomers on CFTR Protein in T84 Cells. Treatment of T84 cells with the antisense pair led to a reduction in the amount of measurable CFTR protein as assessed by autoradiography (Fig. 1) (Fig. 2) . Nearly all untreated and senseand misantisense-treated cells responded to CPTcAMP (8 of 8, 7 of 8, and 7 of 7 cells, respectively). CPTcAMP increased the normalized current at + 100 mV from 2.30 + 1.21 (n = 18), 1.56 ± 0.675 (n = 16), and 3.39 + 3.75 (n = 7) pA/pF to 104.0 + 70.1 (n = 8), 68.5 ± 49.3 (n = 8), and 82.9 ± 31.3 (n = 7) pA/pF, in untreated and sense-and misantisense-treated T84 cells, respectively.
Measurement of reversal potentials established that outward current at depolarized potentials was carried predominantly by Cl-ions. In all of the electrophysiological experiments, Na+ was absent and K+ currents were blocked by including 140 mM Cs+ in the intracellular (pipette) buffer (16) Cells. Whole-cell currents induced by ionomycin, a Ca2+ ionophore, are shown in Fig. 2 . These voltage-clamp records display a slow time-dependent activation at strongly depolarizing potentials. Also, the steady-state current-voltage relation shows greater outward rectification than was observed for the cAMP-induced Cl-current, as observed in T84 (15, 17) and airway epithelial cells (16 Antisense oligomers had essentially no effect on the ionomycin-induced Cl-current, in contrast to their effect on the CPTcAMP-induced Cl-current (Fig. 2) . All untreated and 24-h and 48-h antisense-and sense-treated cells responded to ionomycin (n = 9, 7, 10, and 8, respectively). The normalized current at +100 mV increased to 75.7 ± 53.3 (n = 9), 87.7 ± 37.3 (n = 7), 80.4 ± 74.6 (n = 10), and 83.2 ± 30.8 (n = 8) pA/pF for untreated and 24-h antisense-treated, 48-h antisense-treated, and 48-h sense-treated cells, respectively, after treatment with ionomycin.
Effect of Oligomers on Cl-Currents in 56FHTE-8o-Cells. Similar results were obtained in 56FHTE-8o-cells (Fig. 3) . CPTcAMP increased the normalized Cl-current in sensetreated 56FHTE-8o-cells from 1.59 ± 0.85 to 40.0 ± 23.2 pA/pF in four of four cells, a level similar to that previously observed (16) . Incubation with antisense oligomers reduced the amount of cAMP-dependent Cl-current and the number of cAMP-responders. Three of five cells treated for 48 h with antisense oligomers did not respond to CPTcAMP, and the mean maximal response of the five cells was only 10%o of that of sense-treated cells. In contrast, antisense oligomers had no effect on whole-cell Cl-in response to the Ca2+ ionophore (Fig. 3) . Ionomycin increased the normalized Cl-current at +100 mV from 1.43 ± 0.84 and 2.42 ± 1.58 pA/pF to 70.7 ± 44.5 (n = 5) and 45.9 + 41.9 (n = 4) pA/pF in 48-h antisenseand sense-treated 56FHTE-8o-cells, respectively. DISCUSSION Antisense oligodeoxynucleotides to CFTR markedly reduced the amount of CFTR protein in T84 cells. The observation that the amount of CFTR protein was lowered to 14-24% of the level in untreated cells after a 24-to 48-h incubation with antisense oligomers (Fig. 1) 29 and 10% of the control value after 24-and 48-h incubations, respectively (Fig. 2B) . These kinetics indicate that the half-life of functional CFTR is <24 h, in agreement with the estimates cited above. In T84 cells, the amount of CFTR protein and the magnitude of the cAMP-dependent Clcurrent are strongly correlated (r = 0.98; P < 0.001). However, the relationship between CFTR protein and cAMPdependent Cl-current in airway cells is uncertain. We and others (20, 21) have not detected CFTR protein in airway cells by immunoprecipitation and in vitro phosphorylation. Nevertheless, we observed a large inhibition of cAMPactivated current by antisense treatment.
In contrast to cAMP-stimulated Cl-currents, Ca2+-activated Cl-current was unaffected by antisense treatment in both colonic and airway epithelial cells. The following lines of experimental evidence suggested that the cAMP and Ca2+ pathways activate separate Cl-conductances in epithelial cells: (i) whole-cell current-voltage relations, (ii) time dependence of whole-cell currents, (iii) relative halide selectivity, (iv) differential inhibition by anionic blockers, (v) additivity of cAMP-induced and Ca2+-induced currents, and (vi) preservation of Ca2+-dependent but not cAMPdependent Cl-flux in CF airway epithelial cells (13) (14) (15) (16) 23) . Although these differences could have been attributed to separate transport proteins, differences in current-voltage relations, selectivity profiles, and gating properties could also result from different multimeric structures or covalent modification of the same protein (24, 25) . The preservation of Ca2+-activated Cl-current in cells in which CFTR has been reduced by antisense treatment definitively demonstrates that the cAMP and Ca2+ pathways are also separate with respect to the involvement of CFTR; specifically, in both colonic and airway epithelial cells, CFTR is required for the cAMP pathway but not for the Ca2+ pathway. Antisense treatment may prove useful as a means of identifying other CFTR-independent Cl-flux pathways.
The flow of information in these parallel pathways for the activation of Cl-channels is shown in Fig. 4 . The cAMP pathway is triggered by the binding of a hormone to receptor 1 (e.g., epinephrine to af-adrenergic receptor). The stimulatory guanine nucleotide-binding (G) protein Gs then stimulates adenylate cyclase to form cAMP. Increased cAMP levels result in the activation of PKA, which in turn phosphorylates and increases the open probability of the CFTR Cl-channel (9, 11) . In CF, the amount of functional CFTR is apparently diminished (26, 27) . The Ca2+ pathway is triggered by the binding of a hormone to receptor 2 (e.g., acetylcholine to a muscarinic receptor). A phospholipase C-specific G protein then activates phospholipase C, which in turn hydrolyzes phosphatidylinositol 4,5-bisphosphate to inositol 1,4,5-trisphosphate (1P3) and diacylglycerol. IP3 releases Ca2+ from stores in the endoplasmic reticulum. Ca2+-calmodulin activates CaMK, which phosphorylates and, thereby, increases the open probability of the Ca2+-dependent Cl-channels (16, 17) . The Ca2+ pathway for Cl-channel regulation operates normally in CF airway epithelial cells (13) (14) (15) (16) .
The presence of a normal Ca2+ pathway in CF airway epithelial cells suggests a potential means of circumventing the CF defect. The challenge is to activate the Ca2+ pathway to generate Cl-flux without triggering adverse side effects. Knowles et al. (28) have found that ATP and UTP acting through nucleotide P2 receptors increase Cl-secretion in the airway of CF patients and normal controls. Nucleotide P2 receptors are known to activate phospholipase C and cause an accumulation of IP3 and a consequent increase in intracellular Ca2+ (29) . It seems likely that CaMK then mediates Cl-channel opening (16, 17) , as depicted in Fig. 4 . The increase in intracellular Ca2+ caused by nucleotide triphosphates is short-lived (ref. 30 ; A. C. Chao and P.G., unpublished observations), but the activation of Cl-current is long-lasting (28) . A brief Ca2+ transient may activate CaMK for a much longer duration by inducing its autophosphorylation, which makes it active even at low Ca2+ (31) . Alternatively, CaMK-activated Cl-channels may account for only
